News Summary: FDA investigates 2 patient deaths

THE INVESTIGATION: Federal regulators are looking into the deaths of two patients who received injections of a longer-lasting version of Eli Lilly's antipsychotic Zyprexa.

THE CIRCUMSTANCES: The Food and Drug Administration said the patients died three to four days after receiving an appropriate dose of the drug Zyprexa Relprevv.

STATUS UPDATE: An FDA representative said doctors can continue to use the drug as long as they follow the plan for administering that comes with it. The plan calls for patients to be monitored for three hours at the site where they received the injection and then be accompanied home by someone.